VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
36 hedge funds and large institutions have $1.61M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
36
Holding in Top 10
–
Calls
$484K
Puts
–
Top Buyers
| 1 | +$3K | |
| 2 | +$2.15K | |
| 3 | +$1.23K | |
| 4 |
Goldman Sachs
New York
|
+$506 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$96 |
Top Sellers
| 1 | -$73.3K | |
| 2 | -$40.2K | |
| 3 | -$19.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$14.4K |
| 5 |
Renaissance Technologies
New York
|
-$5.82K |